|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Found 40 studies with search of: | "Mumps" |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Recruiting |
The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants
|
||||
| 22 | Active, not recruiting |
A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers
|
||||
| 23 | Completed |
Safety Study of a Refrigerator-Stable Formulation of VARIVAX®
|
||||
| 24 | Completed |
Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route
|
||||
| 25 | Active, not recruiting |
Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age
|
||||
| 26 | Recruiting |
Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis
|
||||
| 27 | Completed |
Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age
|
||||
| 28 | Active, not recruiting |
Comparative Study of Immunogenicity and Safety of a 2-Dose Regimen of ProQuad® Manufactured With rHA
|
||||
| 29 | Completed |
ProQuad® Intramuscular vs Subcutaneous
|
||||
| 30 | Completed |
V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine
|
||||
| 31 | Completed |
MMR and Varicella Vaccine in Premature Infants
|
||||
| 32 | Completed |
Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children
|
||||
| 33 | Active, not recruiting |
Immunogenicity & Safety of Hepatitis A Vaccine co-Admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children
|
||||
| 34 | Completed |
Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children
|
||||
| 35 | Completed |
Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months
|
||||
| 36 | Completed |
Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children
|
||||
| 37 | Completed |
A Measles, Mumps, and Rubella Investigational Vaccine Trial
|
||||
| 38 | Recruiting |
Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Toddlers
|
||||
| 39 | Active, not recruiting |
A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group
|
||||
| 40 | Active, not recruiting |
Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
|
|
Previous Page (1-20) | Studies Shown (21-40) | Next Page |
|
